Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection (vol 14, 1201505, 2023)

被引:0
|
作者
Guo, Xiaomin [1 ]
An, Yanxing [1 ]
Tan, Wanmin [2 ]
Ma, Ling [2 ]
Wang, Mingyang [2 ]
Li, Juyan [2 ]
Li, Binghong [2 ]
Hou, Wei [1 ]
Wu, Li [2 ]
机构
[1] Shanxi Agr Univ, Coll Vet Med, Jinzhong, Peoples R China
[2] Kunming Med Univ, Dept Med Imaging, Affiliated Hosp 1, Kunming, Peoples R China
关键词
cathelicidins; antiviral peptide; HSV-1; facial palsy; WL-1;
D O I
10.3389/fmicb.2023.1254775
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] A tug of war: DNA-sensing antiviral innate immunity and herpes simplex virus type I infection (vol 10, 2627, 2019)
    Lin, Yingying
    Zheng, Chunfu
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [42] BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines (vol 80, 104814, 2020)
    Iqbal, Aqsa
    Suryawanshi, Rahul
    Yadavalli, Tejabhiram
    Volety, Ipsita
    Shukla, Deepak
    ANTIVIRAL RESEARCH, 2022, 200
  • [43] Antiviral effects of Cacicol®, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection
    Deback, Claire
    Rousseau, Antoine
    Breckler, Magali
    Molet, Lucie
    Boutolleau, David
    Burrel, Sonia
    Roque-Afonso, Anne-Marie
    Labetoulle, Marc
    ANTIVIRAL THERAPY, 2018, 23 (08) : 665 - 675
  • [44] CAP37-Derived Antimicrobial Peptides Have In Vitro Antiviral Activity against Adenovirus and Herpes Simplex Virus Type 1
    Gordon, Y. Jerold
    Romanowski, Eric G.
    Shanks, Robert M. Q.
    Yates, Kathleen A.
    Hinsley, Heather
    Pereira, H. Anne
    CURRENT EYE RESEARCH, 2009, 34 (03) : 241 - 249
  • [45] BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines
    Iqbal, Aqsa
    Suryawanshi, Rahul
    Yadavalli, Tejabhiram
    Volety, Ipsita
    Shukla, Deepak
    ANTIVIRAL RESEARCH, 2020, 180
  • [46] Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis
    Al-Zoobaee, Farah Wasim Aribi
    Shen, Loo Yee
    Veettil, Sajesh K.
    Gopinath, Divya
    Maharajan, Mari Kannan
    Menon, Rohit Kunnath
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (23)
  • [47] A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots
    Falanga, Annarita
    Vitiello, Maria Teresa
    Cantisani, Marco
    Tarallo, Rossella
    Guarnieri, Daniela
    Mignogna, Eleonora
    Netti, Paolo
    Pedone, Carlo
    Galdiero, Massimiliano
    Galdiero, Stefania
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (06) : 925 - 934
  • [48] Antiviral activity of Bifidobacterium adolescentis SPM 0214 against Herpes Simplex Virus Type 1 (vol 35, pg 1665, 2012)
    An, Hyang Mi
    Lee, Do Kyung
    Kim, Jung Rae
    Lee, Si Won
    Cha, Min Kyeong
    Lee, Kang Oh
    Ha, Nam Joo
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (01) : 137 - 137
  • [49] Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells (vol 94, e00994, 2020)
    Zheng, Wenxiao
    Klammer, Alissa M.
    Naciri, Jennifer N.
    Yeung, Jason
    Demers, Matthew
    Milosevic, Jadranka
    Kinchington, Paul R.
    Bloom, David C.
    Nimgaonkar, Vishwajit L.
    D'Aiuto, Leonardo
    JOURNAL OF VIROLOGY, 2021, 95 (04)
  • [50] INFECTION WITH ADENOASSOCIATED VIRUS TYPE-5 INHIBITS MUTAGENICITY OF HERPES-SIMPLEX VIRUS TYPE-1 OR 4-NITROQUINOLINE-1-OXIDE
    SCHLEHOFER, JR
    HEILBRONN, R
    MUTATION RESEARCH, 1990, 244 (04): : 317 - 320